Summary of Product Characteristics
last updated on the eMC:
30/05/2008
When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.
Updated on 30/05/2008 and displayed until Current
|
Reasons for adding or updating:
|
-
Change to joint SPC covering all presentations
|
| Date of revision of text on the SPC: 01-May-2008 |
| Legal Category: POM |
| Black Triangle (CHM):
NO |
Free-text change information supplied by the pharmaceutical company
|
We are replacing the joint SPC for Vibramcyin D 100 mg and 50 mg with two seperate SPCs. All other products currently associated with these SPCs will be retired. We are going to submit the SPC for 100 mg as a new SPC.
If you have any further questions please feel free to call.
|
|
Updated on 20/09/2006 and displayed until 30/05/2008
|
Reasons for adding or updating:
|
-
Change to joint SPC covering all presentations
|
| Date of revision of text on the SPC: 09/2006 |
| Legal Category: POM |
| Black Triangle (CHM):
NO |
Free-text change information supplied by the pharmaceutical company
|
Removal of Vibramycin Capsules 100 mg from the joint SPC.
|
|
Updated on 26/10/2004 and displayed until 20/09/2006
|
Reasons for adding or updating:
|
-
Change to section 3 - pharmaceutical form
-
Change to section 6.1 - List of Excipients
|
|
Updated on 07/11/2002 and displayed until 26/10/2004
|
Reasons for adding or updating:
|
-
Addition of Legal Category
|
|
Updated on 06/11/2002 and displayed until 07/11/2002
|
Reasons for adding or updating:
|
-
Change to section 4.2 - Posology and Method of Administration
-
Change to section 4.3 - Contra-indications
-
Change to section 4.4 - Special Warnings and Precautions for Use
-
Change to section 4.5 - Interactions with other Medicaments and other forms of Interaction
-
Change to section 4.7 - Effects on Ability to Drive and Use Machines
-
Change to section 4.8 - Undesirable Effects
|
|
Updated on 09/10/2001 and displayed until 06/11/2002
|
Reasons for adding or updating:
|
-
Change to section 4.4 - Special Warnings and Precautions for Use
-
Change to section 4.5 - Interactions with other Medicaments and other forms of Interaction
-
Change to section 4.8 - Undesirable Effects
-
Change to section 10 (date of (partial) revision of the text
|
|
Updated on 24/08/2001 and displayed until 09/10/2001
|
Reasons for adding or updating:
|
-
Transferred from eMC version 1
|
|
Updated on 07/09/2000 and displayed until 24/08/2001
|
Reasons for adding or updating:
|
|
|
|
Updated on 06/09/1999 and displayed until 07/09/2000
|
Reasons for adding or updating:
|
|
|
|